Battling ‘Sludge’ in Clinical Trials: A Call to Action
The concept of sludge provides an invaluable lens for clinical research professionals in identifying and mitigating unnecessary friction and bottlenecks.
The concept of sludge provides an invaluable lens for clinical research professionals in identifying and mitigating unnecessary friction and bottlenecks.
There are still a lot of challenges facing pharmaceuticals, med tech, and biotech companies that seek to begin a clinical trial post-COVID. But the obstacles
Increased diversity. Faster enrollment. Reduction in costs. These are just a few of the myriad benefits of the virtual clinical trial touted by CROs and
Krystyna Kowalczyk joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss innovation and leadership in oncology clinical trials. The founder
We recently spoke with Liz Beatty, Chief Strategy Officer at Inato about how the company is disrupting the industry’s approach to site selection. The company
Along with most major clinical operations conferences, the Outsourcing in Clinical Trials event series is virtual in 2021. The ArcheMedX team is excited to exhibit
Choosing the right way to train clinical trial staff is complex and exhausting under normal circumstances. Today’s immense pressure to accommodate new virtual working styles
Paul Evans of Velocity Clinical Research talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, to discuss best practices for sites making the
Need to virtualize everything you can in your clinical trial? Check out these 7 tips to transform the content you deliver to investigators, sites, personnel, and trial team members.
Mary Costello talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, about how clinical research site management is changing – and marching towards
R’Kes Starling joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss how decentralized clinical trials (DCTs) can expand access to
We recently spoke about virtual and hybrid clinical trials with Amy O’Sullivan, Director of North American Operations at SCOPE International, an independent full-service CRO serving
When a Sponsor chooses to engage with a contract research organization (CRO), the Sponsor team expects quality and performance in return for their investment. CROs
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
Get new original content and a hand-curated selection of the best life science articles from around the web directly in your inbox. Subscribe to The ArcheMedX Clinical Research Newsletter
See how ArcheMedX applies behavioral science to transform learning and generate actionable insights